PM
Paul Matteis Stifel Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Vertex Pharmaceuticals
VRTX
$102B
| $396.93 | $455 |
15%
upside
| Hold | 1 month ago |
|
2
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $174 |
24%
upside
| Buy | 1 month ago |
|
3
Dyne Therapeutics
DYN
$1.88B
| $13.24 | $36 |
172%
upside
| Buy | 1 month ago |
|
4
Rhythm Pharmaceuticals
RYTM
$6.95B
| $104.57 | $94 |
10%
downside
| Buy | 3 months ago |
|
5
Alnylam Pharmaceuticals
ALNY
$59.4B
| $453.54 | $345 |
24%
downside
| Buy | 5 months ago |
|
6
Neumora Therapeutics
NMRA
$264M
| $1.63 | $2 |
23%
upside
| Hold | 6 months ago |
|
|
SION
7
Sionna Therapeutics, Inc. Common Stock
SION
$1.02B
| $23.06 | $32 |
39%
upside
| Buy | 6 months ago |
|
8
GH Research
GHRS
$872M
| $14.05 | $32 |
128%
upside
| Buy | 6 months ago |
|
|
CMPS
9
Compass Pathways
CMPS
$489M
| $5.10 | $11 |
116%
upside
| Buy | 6 months ago |
|
10
uniQure
QURE
$973M
| $17.73 | $32 |
80%
upside
| Buy | 8 months ago |
|
11
Alector
ALEC
$285M
| $2.82 | $4 |
42%
upside
| Hold | 8 months ago |
|
12
Neurogene
NGNE
$280M
| $19.61 | $60 |
206%
upside
| Buy | 9 months ago |
|
13
Alkermes
ALKS
$4.77B
| $28.92 | $36 |
24%
upside
| Buy | 10 months ago |
|
14
BioMarin Pharmaceuticals
BMRN
$10.9B
| $56.75 | $87 |
53%
upside
| Buy | 11 months ago |
|
|
RAPP
15
Rapport Therapeutics
RAPP
$560M
| $15.35 | $35 |
128%
upside
| Buy | 1 year ago |
|
16
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $53 |
11%
downside
| Hold | 1 year ago |
|
17
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $21 |
18%
downside
| Hold | 1 year ago |
|
|
CTNM
18
Contineum Therapeutics
CTNM
$308M
| $10.99 | $29 |
164%
upside
| Buy | 1 year ago |
|
19
Biogen
BIIB
$20.5B
| $139.94 | $287 |
105%
upside
| Buy | 1 year ago |
|
20
Lexeo Therapeutics
LXEO
$268M
| $4.97 | $20 |
302%
upside
| Buy | 1 year ago |
|
21
KalVista Pharmaceuticals
KALV
$765M
| $15.20 | $32 |
111%
upside
| Buy | 3 years ago |
|
|
AVDL
22
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $14 |
7%
downside
| Buy | 5 years ago |
|